-

Summit Partners Closes Fourth Europe Growth Equity Fund at €1.4 Billion

BOSTON & LONDON--(BUSINESS WIRE)--Summit Partners, a global alternative investment firm, today announced the first and final closing of its newest Europe growth equity fund. Summit Partners Europe Growth Equity Fund IV closed at its hard cap with €1.4 billion in total commitments. Launched in October 2022, the fund was oversubscribed.

“With the closing of this new fund, we further our commitment to Summit’s growth equity strategy across Europe, serving as the partner of choice for category-leading, profitable growth companies within our core sectors of focus,” said Peter Chung, Managing Director and Chief Executive Officer of Summit Partners. “We are deeply grateful for the continued support of our limited partners and for their trust and confidence in our global team and our growth-focused strategy.”

Summit Partners Europe Growth Equity Fund IV will target minority and majority equity investments between €20 and €80 million in Europe-based companies, applying the growth equity strategy the firm pioneered in 1984.

“As we invest this fund in Europe, we will build upon nearly 40 years of experience as a growth investor, leveraging our deep sector knowledge, extensive global network and value enhancement resources to support the growth of our portfolio companies,” said Han Sikkens, Managing Director and Head of Europe at Summit Partners. “Europe has been an integral part of Summit’s global investment strategy since 2000, and we have been proud to partner with exceptional founders and management teams over that time.”

Summit’s London-based team collaborates closely with the firm’s global team of more than 115 investment professionals, working together to identify and partner with growth companies in key industry sectors, including technology, healthcare and life sciences, and growth products and services. As active board members and through dedicated value enhancement resources, Summit offers its portfolio company leaders strategic support focused on areas we believe are critical to accelerating and supporting long-term, profitable growth, including human capital, go-to-market and operations, technology and data science, and capital markets.

Since the firm’s inception in 1984, Summit Partners has raised more than $43 billion in capital.

About Summit Partners

Founded in 1984, Summit Partners is a global alternative investment firm with capital dedicated to pursuing growth equity, fixed income, and public equity opportunities. Summit invests across growth sectors of the economy and has invested in more than 550 companies in healthcare, technology, and other growth industries. Summit maintains offices in North America and Europe and invests in companies around the world. For more information, please see www.summitpartners.com or Follow on LinkedIn.

In the United States of America, Summit Partners operates as an SEC-registered investment adviser. In the United Kingdom, this document is issued by Summit Partners LLP, a firm authorized and regulated by the Financial Conduct Authority. Summit Partners LLP is a limited liability partnership registered in England and Wales with registered number OC388179 and its registered office is at 11-12 Hanover Square, London, W1S 1JJ, UK. This document is intended solely to provide information regarding Summit Partners' potential financing capabilities for prospective portfolio companies.

Contacts

Summit Partners


Release Summary
Summit Partners announces the closing of its fourth Europe growth equity fund, which closed at its hard cap with €1.4 billion in total commitments.
Release Versions

Contacts

Social Media Profiles
More News From Summit Partners

Summit Partners Announces Growth Investment in Dreampath Diagnostics to Accelerate Digital Transformation in Anatomical Pathology

LONDON & BOSTON & STRASBOURG, France--(BUSINESS WIRE)--Summit Partners today announced a growth investment in Dreampath Diagnostics, a leading healthcare technology company focused on digitizing workflows in anatomical pathology laboratories. The investment will support the company’s plans to accelerate global growth, scale operations and expand its commercial reach and product portfolio. Founded in 2012, Dreampath offers a patented suite of traceability solutions and consumables designed to au...

RIS Rx Announces Growth Investment from Summit Partners to Combat Revenue Leakage in Pharma Patient Affordability Programs

NEWPORT BEACH, Calif.--(BUSINESS WIRE)--RIS Rx, a healthcare technology company pioneering solutions to reduce revenue leakage in pharmaceutical gross-to-net spread, today announced a significant growth investment from Summit Partners. This partnership will support RIS Rx’s continued innovation and growth in service of the company’s commitment to improving patient access to treatment, one prescription at a time. Founded in 2020 by pharmacists Gerard Rivera and Stephen Hom, RIS Rx was born out o...

Simply.TV Expands in North America with Acquisition of Red Bee Media’s Content Discovery Business and Announces Growth Investment from Summit Partners

COPENHAGEN, Denmark--(BUSINESS WIRE)--Simply.TV, a leading video metadata provider, today announced the acquisition of Red Bee Media’s Content Discovery Business, further accelerating Simply.TV’s global expansion and strengthening the company’s position in the U.S. market. In conjunction with this acquisition, Simply.TV has secured a majority growth equity investment from Summit Partners, marking the company’s first institutional funding. Founded in 2019 by Morten Trolle and Daniel Rühmann, Sim...
Back to Newsroom